
Mecofar-G Tablet
Marketer
Scott Edil Pharmacia Ltd
Salt Composition
Gabapentin (300mg) + Methylcobalamin (500mcg)
Overview Mecofar-G Tablet
Neuropathic pain is effectively managed with Mecofar-G tablets, a combination medication. Its mechanism involves modulating nerve cell calcium channel activity to reduce pain sensation. Administered orally, Mecofar-G can be taken with or without food, ideally before sleep, maintaining consistent daily timing for optimal blood levels. Always adhere to your physician's prescribed dosage and duration. Missed doses should be taken immediately upon recall. Complete the entire treatment regimen, even with symptom improvement. Discontinuation requires prior consultation with your doctor. Common adverse effects include nausea, peripheral swelling, incoordination, blurred vision, fever, and involuntary eye movement (nystagmus). Dizziness and drowsiness may occur; avoid driving or activities requiring concentration until effects are known. Report any unusual mood or behavioral changes, new or worsening depression, or suicidal ideation to your doctor immediately. Pregnant, breastfeeding, or planning pregnancy should be disclosed before commencing treatment. While generally safe to combine with other medications, interactions with certain drugs (including antacids and alcohol) can alter its efficacy and increase adverse reaction risk.
Primary Ingredients of Mecofar-G Tablet
No text was provided to rewrite.
Uses of Mecofar-G Tablet
Managing neuropathic pain
Major Benefits of Mecofar-G Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mecofar-G Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Mecofar-G Tablet:
- Dizziness
- Sleepiness
- Tiredness
- Uncoordinated body movements
How to use Mecofar-G Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mecofar-G Tablets can be administered with or without food; however, consistent timing is recommended.
How Mecofar-G Tablet works:
Mecofar-G Tablets contain Gabapentin and Methylcobalamin, working synergistically to alleviate neuropathic pain. Gabapentin, an alpha-2-delta ligand, reduces pain signals by modulating nerve cell calcium channels. Methylcobalamin, a B vitamin, supports myelin sheath production, protecting and repairing nerve fibers. This combined action provides effective relief from nerve-related pain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Mecofar-G tablets and alcohol may lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Mecofar-G Tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Use of Mecofar-G tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant. However, monitor the infant for drowsiness and unusual weight increase.
DrivingUNSAFE
Taking Mecofar-G Tablets might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if such effects are experienced.
KidneyCAUTION
Patients with impaired kidney function should use Mecofar-G Tablets cautiously, potentially requiring a modified dosage. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding Mecofar-G Tablet use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Mecofar-G Tablet :
Should you forget a Mecofar-G Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mecofar-G Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
